Profile picture

Doctor Takashi Unoki

Saiseikai Kumamoto Hospital, Kumamoto (Japan)
Follow
Logo ESC

Contributor content

Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO
Presentation
Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO
Percutaneous coronary intervention on combined VA-ECMO and IMPELLA (ECPELLA) support may reduce myocardial damage in cardiogenic shock patients with STEMI who required mechanical circulatory support
Presentation
Percutaneous coronary intervention on combined VA-ECMO and IMPELLA (ECPELLA) support may reduce myocardial damage in cardiogenic shock patients with STEMI who required mechanical circulatory support
Combined use of VA-ECMO and IMPELLA (ECPELLA) as a possible strategy to improve outcomes in patients who underwent E-CPR
Presentation
Combined use of VA-ECMO and IMPELLA (ECPELLA) as a possible strategy to improve outcomes in patients who underwent E-CPR
Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study
Presentation
Growth differentiation factor-15 and mortality in suspected or known coronary heart disease patients with diabetes: a subanalysis of the ANOX study
Vascular endothelial growth factor-C and mortality in patients with suspected but no history of coronary heart disease: a subanalysis of the ANOX study
Presentation
Vascular endothelial growth factor-C and mortality in patients with suspected but no history of coronary heart disease: a subanalysis of the ANOX study
Vascular endothelial growth factor-C and mortality in patients with diabetes and suspected coronary artery disease: from the ANOX study
Presentation
Vascular endothelial growth factor-C and mortality in patients with diabetes and suspected coronary artery disease: from the ANOX study
Serum-amyloid-A/LDL complex independently correlated with angiographic severity of coronary artery disease in patients with previous history of cardiovascular events: baseline data from the ANOX study
Presentation
Serum-amyloid-A/LDL complex independently correlated with angiographic severity of coronary artery disease in patients with previous history of cardiovascular events: baseline data from the ANOX study
Serum vascular endothelial growth factor-C levels as an indicator of in-stent restenosis and/or development of coronary new lesion after drug-eluting stent implantation
Presentation
Serum vascular endothelial growth factor-C levels as an indicator of in-stent restenosis and/or development of coronary new lesion after drug-eluting stent implantation

ESC 365 is supported by